Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 595 issues

Renewing Mepsevii (vestronidase alfa-vjbk) Approval with Blue Cross Blue Shield in Washington: 2025 Requirements & Timeline

Answer Box: Blue Cross Blue Shield requires annual prior authorization renewal for Mepsevii (vestronidase alfa-vjbk) in Washington, with updated documentation 60-90 days before expiration. Key requirements: confirmed MPS VII diagnosis via enzyme/genetic testing, current specialist prescription, evidence of ongoing clinical benefit, and proper dosing verification. Start renewal preparation 3
4 min read

How to Get Advate (Octocog Alfa) Covered by Blue Cross Blue Shield in Florida: Coding, Appeals, and Success Strategies

Answer Box: Getting Advate Covered in Florida Advate (octocog alfa) requires prior authorization from Blue Cross Blue Shield Florida, with strict documentation requirements for hemophilia A patients. Success depends on proper coding (ICD-10 D66), specialist prescribing, and comprehensive clinical documentation. Three-step fast track: 1) Gather factor VIII levels, bleed history,
7 min read

How to Get Tegsedi (Inotersen) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Appeal Guide with Forms and Timelines

Quick Answer: Getting Tegsedi Covered by BCBS in Pennsylvania Blue Cross Blue Shield prior authorization for Tegsedi (inotersen) requires: genetic confirmation of hATTR polyneuropathy, documented step therapy failures, REMS enrollment, and a comprehensive lab monitoring plan. If denied, you have 180 days for internal appeals, then 4 months for Pennsylvania&
5 min read